topcat
Well-Known Member
Too true. This is bringing out the worst in me, I want to go back to "Give Peace a Chance". Now, form your drum circles.
Hydroxychloroquine, yes I would take it, or fuck Trump?
- Thread starter Bugeye
- Start date
DIY-HP-LED
Well-Known Member
Personally, this is a good thread to drop a drone video on.. I can't fly this summer so I never even bothered ordering fresh batteries and after that we'll be regulated out of existence. I don't feel bad about spamming this thread at all.Too true. This is bringing out the worst in me, I want to go back to "Give Peace a Chance". Now, form your drum circles.
One Pack Bando (6S) | FPV FREESTYLE
Fogdog
Well-Known Member
You are joking, right?
This is just more woo-woo science. One "study" of happenstance data. Small sample size, no replication of results, no peer review, no mechanism to explain the relatively small differences.
Does Your Blood Type Increase Your Risk for Coronavirus?
Experts say past studies have shown a connection between blood types and certain conditions and illnesses, but more research needs to be done on the possible link to COVID-19 risk.
www.healthline.com
The recent study came out of Wuhan, China, where the first known cases of COVID-19 were discovered. It’s published on a website, but hasn’t yet been reviewed by peers.
In the study, scientists looked at the blood types of 2,173 people who had been diagnosed with COVID-19 and compared that with the blood types of the general population in that region.
They found that in the normal population, type A was 31 percent, type B was 24 percent, type AB was 9 percent, and type O was 34 percent.
In those with the virus, type A was 38 percent, type B was 26 percent, type AB was 10 percent, and type O was 25 percent.
The researchers concluded that “blood group A had a significantly higher risk for COVID-19 compared with non-A blood groups. Whereas blood group O had a significantly lower risk for the infectious disease compared with non-A blood groups.”
I've made a career out of sticking to facts and testing conclusions before making recommendations. So, thanks to all those who believe shit like this. Science wins at the end of the day. Too bad for those that died in ignorance. I'm sorry for them.
Last edited:
Unclebaldrick
Well-Known Member
Fogdog
Well-Known Member
I don't have malaria or lupus. So, nope. No need for it.
Every person admitted to a NY hospital has been prescribed hydroxychloroquine if safe for them. Right now 10,000 people are in hospital for Covid-19 in NY. Yesterday, 900 people died, setting a new record. In all, 6000 died. Hydrochloroquine doesn't help whatsoever. Its a false hope.
Maybe Trump should switch to advising coco-butter? What do you have to lose? At least the corpse will smell better.
Last edited:
DIY-HP-LED
Well-Known Member
May you never need a ventilator, actual humans get them first.
rkymtnman
Well-Known Member
The idea that the combination of hydroxychloroquine with an antibiotic drug, azithromycin, was effective against COVID-19 gained more attention after a study published on March 17. This study described a trial of 80 patients carried out by Philippe Gautret in Marseille, France. Although some of their results appeared to be encouraging, it should also be noted that most of their patients only had mild symptoms. Furthermore, 85% of the patients didn’t even have a fever – one of the major telltale symptoms of the virus, thus suggesting that these patients likely would have naturally cleared the virus without any intervention.
A second French group, led by Jean-Michel Molina, has now tested the hydroxychloroquine-azithromycin combination treatment in 11 patients at the Hôpital Saint-Louis in Paris, France, and their results were strikingly different.
Like the Marseille study, the Molina trial was also a small pilot study. Molina and colleagues used the same dosing regimen as Gautret. In contrast, however, to the Gautret study, eight of the 11 patients had underlying health conditions, and 10 of 11 had fevers and were quite ill at the time the dosing began.
These Paris researchers found that after five to six days of treatment with hydroxychloroquine (600 mg per day for 10 days) and azithromycin (500 mg on day 1 and 250 mg on days 2 to 5), eight of the 10 patients still tested positive for COVID-19. Of these 10 patients, one patient died, two were transferred to the ICU and another had to be removed from the treatment due to serious complications.
Looks promising to me Bug. LOL. I'll save you my dose.
A second French group, led by Jean-Michel Molina, has now tested the hydroxychloroquine-azithromycin combination treatment in 11 patients at the Hôpital Saint-Louis in Paris, France, and their results were strikingly different.
Like the Marseille study, the Molina trial was also a small pilot study. Molina and colleagues used the same dosing regimen as Gautret. In contrast, however, to the Gautret study, eight of the 11 patients had underlying health conditions, and 10 of 11 had fevers and were quite ill at the time the dosing began.
These Paris researchers found that after five to six days of treatment with hydroxychloroquine (600 mg per day for 10 days) and azithromycin (500 mg on day 1 and 250 mg on days 2 to 5), eight of the 10 patients still tested positive for COVID-19. Of these 10 patients, one patient died, two were transferred to the ICU and another had to be removed from the treatment due to serious complications.
Looks promising to me Bug. LOL. I'll save you my dose.
Gond00s
Well-Known Member
I heard chloroquine stays in your system for a while and its more easy to overdose on it but I could be wrong
Last edited:
rkymtnman
Well-Known Member
i think i'd take my chances with a bottle of Patron over Trump's recommendation.
Bugeye
Well-Known Member
No need, but thank you!
Gond00s
Well-Known Member
hey u joining in too I got a big bottle of rum with my name on it about 1/4 thru it so far
Fogdog
Well-Known Member
Another disease that is not affected by hydroxychloroquine goes by the common term of "stupidity".
Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”
The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.
The April 3, 2020, notice, from the International Journal of Antimicrobial Agents, states that the March 20 article, “Hydroxychloroquine and azithromycin as a treatment of Covid-19: results of an open-label non-randomized clinical trial”
Last month, Elisabeth Bik took a close look at the IJAA article and detailed a long list of serious problems with the study, including questions about its ethical underpinnings, messy confounding variables, missing patients, rushed and conflicted peer review, and confusing data.
Others have used PubPeer to report additional issues with the Raoult article.
retractionwatch.com
Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”
The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.
The April 3, 2020, notice, from the International Journal of Antimicrobial Agents, states that the March 20 article, “Hydroxychloroquine and azithromycin as a treatment of Covid-19: results of an open-label non-randomized clinical trial”
The notice, which is from the ISAC and not the journal itself, is a bit ambiguous. The society says it “shares the concerns” about the paper, but it doesn’t appear to be taking additional action.
Last month, Elisabeth Bik took a close look at the IJAA article and detailed a long list of serious problems with the study, including questions about its ethical underpinnings, messy confounding variables, missing patients, rushed and conflicted peer review, and confusing data.
Others have used PubPeer to report additional issues with the Raoult article.
Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”
Didier Raoult The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement …
retractionwatch.com
DIY-HP-LED
Well-Known Member
I wasn't gonna post on this topic any more until a proper study has been done, but...
www.sciencealert.com
----------------------------------------------------------------------------------------------------------------------------------------
Small Trial Suggests Antimalarial Drugs Not Effective For Treating Coronavirus
6 APRIL 2020
On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a "game changer" for COVID-19.
However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body.
more...
Small Trial Suggests Antimalarial Drugs Not Effective For Treating Coronavirus
On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19.
www.sciencealert.com
Small Trial Suggests Antimalarial Drugs Not Effective For Treating Coronavirus
6 APRIL 2020
On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a "game changer" for COVID-19.
However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body.
more...
That drug is old, been around for decades. Has been tested on many other viruses and has never been effective against one virus. It's like trying baking soda or sugar and a few people will think it's works. To say Trump is semiliterate is being kind. I think he is mentally ill and should be tested. No leadership qualities at all. What a time to have gutless bone-spurs in charge when we need much better and stronger leadership.
Attachments
Sir Napsalot
Well-Known Member
Up yours
Bugeye
Well-Known Member
Special best wishes to you!
newgrow16
Well-Known Member
“A couple of careful studies of hydroxychloroquine are in progress, but the results may take weeks or longer. Infectious-disease experts are already using hydroxychloroquine clinically with some success. With our colleague Dr. Joe Brewer in Kansas City, Mo., we are using hydroxychloroquine in two ways: to treat patients and as prophylaxis to protect health-care workers from infection.
“We had been using the protocol outlined in the research from China, but we’ve switched to the combination prescribed in the French study. Our patients appear to be showing fewer symptoms.
“Our experience suggests that hydroxychloroquine, with or without a Z-Pak, should be a first-line treatment. Unfortunately, there is already a shortage of hydroxychloroquine. The federal government should immediately contract with generic manufacturers to ramp up production. Any stockpiles should be released.”
“We had been using the protocol outlined in the research from China, but we’ve switched to the combination prescribed in the French study. Our patients appear to be showing fewer symptoms.
“Our experience suggests that hydroxychloroquine, with or without a Z-Pak, should be a first-line treatment. Unfortunately, there is already a shortage of hydroxychloroquine. The federal government should immediately contract with generic manufacturers to ramp up production. Any stockpiles should be released.”